Skip to Main content Skip to Navigation
Journal articles

Translating epithelial mesenchymal transition markers into the clinic: Novel insights from proteomics

Abstract : The growing understanding of the molecular mechanisms underlying epithelial-to-mesenchymal transition (EMT) may represent a potential source of clinical markers. Despite EMT drivers have not yet emerged as candidate markers in the clinical setting, their association with established clinical markers may improve their specificity and sensitivity. Mass spectrometry-based platforms allow analyzing multiple samples for the expression of EMT candidate markers, and may help to diagnose diseases or monitor treatment efficiently. This review highlights proteomic approaches applied to elucidate the differences between epithelial and mesenchymal tumors and describes how these can be used for target discovery and validation.
Document type :
Journal articles
Complete list of metadata

Cited literature [129 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02940397
Contributor : Michel Salzet Connect in order to contact the contributor
Submitted on : Wednesday, September 16, 2020 - 11:53:10 AM
Last modification on : Wednesday, March 17, 2021 - 2:32:03 PM
Long-term archiving on: : Thursday, December 3, 2020 - 8:01:29 AM

File

1-s2.0-S2212968516300034-main....
Publication funded by an institution

Identifiers

Collections

Citation

Daniele Vergara, Pasquale Simeone, Julien Franck, Marco Trerotola, Anna Giudetti, et al.. Translating epithelial mesenchymal transition markers into the clinic: Novel insights from proteomics. EuPA Open Proteomics, Elsevier, 2016, 10, pp.31-41. ⟨10.1016/j.euprot.2016.01.003⟩. ⟨inserm-02940397⟩

Share

Metrics

Record views

104

Files downloads

91